These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6714113)

  • 21. Alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives.
    Lao B; Czyzyk A; Szutowski M; Szczepanik Z
    Arzneimittelforschung; 1994 Jun; 44(6):727-34. PubMed ID: 8053971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlorpropamide-alcohol flushing and coronary heart disease in non-insulin dependent diabetics.
    Laakso M; Nuorva K; Aro A; Uusitupa M; Siitonen O; Huupponen R
    Br Med J (Clin Res Ed); 1983 Apr; 286(6374):1317-8. PubMed ID: 6404448
    [No Abstract]   [Full Text] [Related]  

  • 23. [Facial vasomotor flushing due to alcohol-chlorpropamide. Prevalence in diabetic and non-diabetic patients].
    Guillausseau PJ; Akoka C; Lubetzki J
    Rev Med Interne; 1984 Sep; 5(3):212-6. PubMed ID: 6505425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of patients with chlorpropamide-alcohol flush.
    Groop L; Koskimies S; Tolppanen EM
    Acta Med Scand; 1984; 215(2):141-9. PubMed ID: 6367367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase of plasma acetaldehyde. An objective indicator of the chlorpropamide alcohol flush.
    Jerntorp P; Ohlin H; Bergström B; Almér LO
    Diabetes; 1981 Sep; 30(9):788-91. PubMed ID: 7262473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of chlorpropamide, alcohol and acetaldehyde in determining the chlorpropamide-alcohol flush.
    Groop L; Eriksson CJ; Huupponen R; Ylikahri R; Pelkonen R
    Diabetologia; 1984 Jan; 26(1):34-8. PubMed ID: 6706043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between chlorpropamide-alcohol flushing and fast acetylator phenotype in type I and type II diabetes.
    Bonisolli L; Pontiroli AE; De Pasqua A; Calderara A; Maffi P; Gallus G; Radaelli G; Pozza G
    Acta Diabetol Lat; 1985; 22(4):305-15. PubMed ID: 3868908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The alcohol-chlorpropamide test: its contribution to the knowledge of non-insulin-dependent diabetes].
    Lubetzki J; Guillausseau PJ
    Presse Med; 1984 May; 13(20):1247-8. PubMed ID: 6232580
    [No Abstract]   [Full Text] [Related]  

  • 29. [Non-insulin-dependent diabetes mellitus. Genetic and metabolic risk factors in the development of micro- and macro-angiopathic complications].
    Pontiroli AE; Calderara A; De Pasqua A; Bonisolli L; Margonato A; Maffi P; Radaelli G; Gallus G; Pozza G
    Minerva Endocrinol; 1986; 11(2):125-38. PubMed ID: 3785117
    [No Abstract]   [Full Text] [Related]  

  • 30. The chlorpropamide alcohol flush.
    Wiles PG; Pyke DA
    Clin Sci (Lond); 1984 Oct; 67(4):375-81. PubMed ID: 6380892
    [No Abstract]   [Full Text] [Related]  

  • 31. Blood concentrations of acetaldehyde during chlorpropamide-alcohol flush.
    Barnett AH; Gonzalez-Auvert C; Pyke DA; Saunders JB; Williams R; Dickenson CJ; Rawlins MD
    Br Med J (Clin Res Ed); 1981 Oct; 283(6297):939-41. PubMed ID: 6793182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To flush or not to flush? Comments on the chlorpropamide-alcohol flush.
    Waldhäusl W
    Diabetologia; 1984 Jan; 26(1):12-4. PubMed ID: 6706041
    [No Abstract]   [Full Text] [Related]  

  • 33. Erythrocyte aldehyde dehydrogenase, plasma chlorpropamide concentrations and the chlorpropamide alcohol flush.
    Hillson RM; Ting HH; Smith RF; Yajnik CS; Crabbe J; Hockaday TD
    Diabete Metab; 1987 Feb; 13(1):23-5. PubMed ID: 3569630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is there an association between diabetic retinopathy and the chlorpropamide-alcohol-flushing syndrome?].
    Zahr M; de los Ríos MG; Mella I; Carrasco E
    Rev Med Chil; 1983 Mar; 111(3):235-9. PubMed ID: 6648103
    [No Abstract]   [Full Text] [Related]  

  • 35. Coronary heart disease in type 2 diabetic patients: common and different risk factors in men and women.
    Lunetta M; Barbagallo A; Attardo T; Crimi S; Sangiorgio L
    Diabetes Metab; 1997 Jun; 23(3):230-1. PubMed ID: 9234001
    [No Abstract]   [Full Text] [Related]  

  • 36. Chlorpropamide-alcohol flushing and large-vessel disease in non-insulin-dependent diabetes.
    Barnett AH; Pyke DA
    Br Med J; 1980 Jul; 281(6235):261-2. PubMed ID: 7427235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of endothelin I and angiotensin II in type 2 diabetics with coronary disease].
    Mundo-Sagardía J; Altieri P; Banch H; González R; Escobales N; Crespo M; Rodríguez-Orengo J; Cardona F; Torrado J
    Bol Asoc Med P R; 2003; 95(5):45-50. PubMed ID: 15008361
    [No Abstract]   [Full Text] [Related]  

  • 38. [Coronary risk assessment in subjects with type 2 diabetes mellitus. General population-based scores or specific scores?].
    Hernáez R; Choque L; Giménez M; Costa A; Márquez JI; Conget I
    Rev Esp Cardiol; 2004 Jun; 57(6):577-80. PubMed ID: 15225505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low incidence of chlorpropamide-alcohol flushing in diet-treated, non-insulin-dependent diabetes.
    deSilva NE; Tunbridge WM; Alberti KG
    Lancet; 1981 Jan; 1(8212):128-31. PubMed ID: 6109802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.